Your browser doesn't support javascript.
loading
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX.
Stroes, Charlotte I; Schokker, Sandor; Molenaar, Remco J; Mathôt, Ron A A; Bijlsma, Maarten F; van der Woude, Stephanie O; Belo Pereira, João P; Hooijer, Gerrit K J; Verhoeven, Rob H A; Cats, Annemieke; Grootscholten, Cecile; van Sandick, Johanna W; Creemers, Geert-Jan; Nieuwenhuijzen, Grard A P; Haj Mohammad, Nadia; Ruurda, Jelle P; Meijer, Sybren L; Hulshof, Maarten C C M; van Berge Henegouwen, Mark I; van Laarhoven, Hanneke W M.
Afiliación
  • Stroes CI; Cancer Center Amsterdam, Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Schokker S; Center for Experimental and Molecular Medicine (CEMM), Cancer Center Amsterdam, Laboratory for Experimental Oncology and Radiobiology (LEXOR), Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Molenaar RJ; Cancer Center Amsterdam, Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Mathôt RAA; Cancer Center Amsterdam, Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Bijlsma MF; Department of Hospital Pharmacy and Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • van der Woude SO; Cancer Center Amsterdam, Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Belo Pereira JP; Oncode Institute, 3521 AL Utrecht, The Netherlands.
  • Hooijer GKJ; Cancer Center Amsterdam, Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Verhoeven RHA; Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Cats A; Department of Pathology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Grootscholten C; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 DT Utrecht, The Netherlands.
  • van Sandick JW; The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gastrointestinal Oncology, 1066 CX Amsterdam, The Netherlands.
  • Creemers GJ; The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gastrointestinal Oncology, 1066 CX Amsterdam, The Netherlands.
  • Nieuwenhuijzen GAP; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.
  • Haj Mohammad N; Department of Medical Oncology, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.
  • Ruurda JP; Department of Surgery, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.
  • Meijer SL; University Medical Center Utrecht, Department of Clinical Oncology, Utrecht University, 3584 CX Utrecht, The Netherlands.
  • Hulshof MCCM; University Medical Center Utrecht, Department of Surgery, 3584 CX Utrecht, The Netherlands.
  • van Berge Henegouwen MI; Department of Pathology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • van Laarhoven HWM; Department of Radiation Oncology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Cancers (Basel) ; 13(4)2021 Feb 17.
Article en En | MEDLINE | ID: mdl-33671266
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos